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Background/aim: To compare the differences in clinical characteristics and disease impact on life between patients with juvenile-onset
ankylosing spondylitis (JoAS) and patients with adult-onset AS (AoAS).
Materials and methods: Demographic and clinical data were collected from 139 AS patients. Disease activity was defined with the
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Functional status was assessed with the Bath Ankylosing Spondylitis
Functional Index (BASFI). Status of quality of life was evaluated with the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire.
Results: There were 50 patients with JoAS (36.0%) and 89 with AoAS (64.0%). The JoAS group showed more onset with peripheral
joints involvement (P < 0.001), significant diagnosis delay (P < 0.001), worse functional status (P = 0.002), and poorer quality of life
(P = 0.002). Patients with JoAS also showed a significantly lower rate in college education (P = 0.037) and marriage (P = 0.013). The
rate of employment in the JoAS group was lower than that in the AoAS group. Although the difference in employment did not reach a
significant level, the JoAS group included more patients who had not been employed since reaching adulthood (P = 0.015).
Conclusion: Compared to patients with AoAS, patients with JoAS may need more specific clinical interventions as well as social
assistance.
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1. Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory
disease of the axial spine and may be further complicated
by the involvement of peripheral joints. It can lead to
significant impairment not only of physical function but
also of comprehensive quality of life in certain aspects (1,2).
AS occurs predominantly in early adulthood, but can also
occur in childhood. When AS occurs at 16 years of age or
earlier it is termed JoAS and when it occurs after the age
of 16 it is termed AoAS (3). Although JoAS shares certain
similar features with AoAS, for example the presence of
radiographic sacroiliitis, it may also have some specific
clinical characteristics that distinguish it from AoAS (4,5).
Most studies reported that JoAS often had a significantly
longer diagnosis delay (6,7) compared with AoAS, whereas
some other studies did not include a comparison of this
aspect (4,8). JoAS has been reported with a higher frequency
of peripheral joint involvement, especially the involvement
of the hip joint. Although hip joint involvement has been
thought to be associated with a worse functional outcome
for AS patients (9), discrepancies exist in the comparison
* Correspondence: hipknee66@163.com

of functional status between JoAS and AoAS. The majority
of present studies reported that JoAS had worse functional
outcomes than AoAS (7,10) while other studies failed
to detect differences between JoAS and AoAS (6,11).
Moreover, there were also sparse reports that reflected
that patients with JoAS might suffer from less functional
impairment than those with AoAS (4,12). Radiographical
differences between JoAS and AoAS have also been assessed
in several studies and JoAS was reported to have caused less
severe axial involvement radiographically compared with
AoAS (4,13). Overall, most of the studies so far have mainly
focused on the differences in aspects of clinical features
between JoAS and AoAS. Studies centering on the potential
differences between JoAS and AoAS in certain important
aspects relating to quality of life, such as educational level,
employment status, and marriage status, remain scarce.
Detection of differences is the precondition for the
development of specific interventions. So, in this study,
we aimed to compare the differences in clinical features as
well as several essential factors related with quality of life
between JoAS and AoAS.
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2. Materials and methods
2.1. AS patients
All of the included patients were at least 18 years old and
met the modified New York classification criteria for AS
(14). The local ethics committee approved the study and
informed consent was obtained from all participants.
2.2. Questionnaire on demographic characteristics
This questionnaire contains a number of demographic
variables, such as current age, sex, educational level,
marital status (married, never married, or divorced),
and employment (employed, never employed, or loss of
employment due to AS).
2.3. Questionnaire on disease characteristics
This questionnaire includes family history, HLA-B27
status, initial symptoms (peripheral or axial), age at onset
of AS symptoms (juvenile onset defined at ≤16 years; adult
onset defined at >16 years), age at diagnosis of AS, disease
activity measured with the Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI) (15), functional
status measured with the Bath Ankylosing Spondylitis
Functional Index (BASFI) (16), and disease-related quality
of life measured with the Ankylosing Spondylitis Quality
of Life (ASQoL) questionnaire (17). Disease duration was
then defined as the interval between the age at the onset
of symptoms and the current age. Diagnosis delay was
defined as the gap between the age at onset of symptoms
and the age at correct AS diagnosis.
2.4. Statistical analysis
Statistical analyses were performed with SPSS 16.0 for
Windows. A chi-squared test was used to compare the
variables in aspects of family history, HLA-B27 status,
sex, and initial symptoms between JoAS and AoAS.
Educational level, employment status, and marriage
status were also compared by a chi-squared test between
the 2 groups. The Mann–Whitney U-test was used to
compare the continuous variables as follows: current age,
diagnostic delay, BASDAI, BASFI, and ASQoL. The level of
significance was set at P < 0.05.
3. Results
3.1. Comparison in demographic and clinical features of
JoAS versus AoAS
Of 139 patients, 50 (36.0%) had JoAS and 89 (64.0%) had
AoAS. The average age at disease onset of JoAS and AoAS
was 13.3 ± 2.3 years and 21.7 ± 4.5 years (P < 0.001); the
average current age was 27.4 ± 7.6 and 28.8 ± 6.7 (P = 0.128);
average disease duration was 14.0 ± 8.2 years and 7.1 ± 5.7
years (P < 0.001) and average age at diagnosis was 18.5 ±
5.2 years and 24.5 ± 5.7 years (P < 0.001) respectively. The
study showed that 106 patients knew about their HLA-B27
status: 81 patients were HLA B27+ while 25 patients were
HLA B27−. A total of 112 patients provided their family
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history: 35 patients had a positive family history while 77
had a negative family history. No statistical differences
were detected in aspects of sex, HLA-B27 status, or family
history between JoAS and AoAS. The JoAS group showed
a more frequent onset with peripheral joint involvement
than the AoAS group (72.0% vs. 24.7%; P < 0.001). Patients
with JoAS suffered from more significant diagnosis delays
than patients with AoAS (5.32 ± 5.26 vs. 2.85 ± 3.82; P
< 0.001). The functional status in JoAS was significantly
worse than that in AoAS (BASFI: 37.33 ± 23.45 vs. 24.71 ±
16.39; P = 0.002). No significant differences were detected
in BASDAI between JoAS and AoAS (4.25 ± 2.08 vs. 3.96 ±
1.95; P = 0.163) (Table 1).
3.2. Comparison of life impact between JoAS and AoAS
Patients with JoAS showed significantly poorer status of
comprehensive quality of life (ASQoL; 8.9 ± 4.6 vs. 6.5 ±
3.2; P = 0.002). Patients with JoAS also showed significantly
lower rates of higher education compared with patients in
the AoAS group (26.0% vs. 43.8%; P = 0.037). With the
exclusion of 17 current college students, the marriage
rate of JoAS patients was significantly lower than that of
AoAS patients (31.7% vs. 55.6%; P = 0.013) and the rate of
employment in the JoAS group was lower than that in the
AoAS group (46.3% vs. 59.3%; P = 0.176). Although the
difference did not reach a significant level, the JoAS group
included more patients who had not been employed since
they reached adulthood compared with the AoAS group
(26.8% vs. 9.9%; P = 0.015) (Table 2).
4. Discussion
In our cohort, 36.0% of patients suffered from JoAS, which
is significantly higher than that of Caucasians (9%–21%)
(7,18) but is lower and closer to the result of a Korean
report (41.3%) (8). The majority of previous studies failed
to find differences in family history between JoAS and
AoAS (4,6,13) while one report reflected that significantly
more patients with AoAS had a positive family history (19).
In the present study, the rate of positive family history in
the AoAS group was slightly higher than that in the JoAS
group, but the difference was not significant (28.4% vs.
22.9%; P = 0.93). A higher proportion of female patients
with JoAS was reported in one study (20), although the
difference was not significant (P = 0.07). We have not
found the differences in sex between JoAS and AoAS
(P = 0.63) reported in most of the other studies (6,7). In
addition, similar to most of the previous studies (4,20),
no significant difference in HLA-B27 status was identified
between the JoAS group and the AoAS group in this study
(P = 0.72).
Probably due to the dramatic fluctuation in disease
activity between AS remission and AS flare, most of the
studies so far have not detected the difference in BASDAI
between JoAS and AoAS (4,6). No significant differences
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Table 2. Comparison in life impact of JoAS versus AoAS.

ASQoL (mean ± SD)
College education or more, n (%)
Married, n (%)
Employment, n (%)
Never employed, n (%)

JoAS
(n = 50)

AoAS
(n = 89)

P

8.9 ± 4.6
13 (26.0)
13 (31.7)
19 (46.3)
11 (26.8)

6.5 ± 3.2
39 (43.8)
45 (55.6)
48 (59.3)
8 (9.9)

0.002
0.037
0.013
0.176
0.015

JoAS: juvenile-onset ankylosing spondylitis
AoAS: adult-onset ankylosing spondylitis
ASQoL: Ankylosing Spondylitis Quality of Life questionnaire
SD: Standard deviation
Table 1. Comparison in demographic and clinical characteristics of JoAS versus AoAS.

Female sex, n (%)
Current age (mean ± SD, years)
Age at symptom onset (mean ± SD, years)
Age at diagnosis (mean ± SD, years)
Disease duration (mean ± SD, years)
Delay in diagnosis (mean ± SD, years)
HLA-B27+, n (%)
Family history of AS, n (%)
Peripheral pattern at disease onset, n (%)
BASFI (mean ± SD)
BASDAI (mean ± SD)

JoAS
(n = 50)

AoAS
(n = 89)

P

9 (18.0)
27.4 ± 7.6
13.3 ± 2.3
18.5 ± 5.2
14.0 ± 8.2
5.32 ± 5.26
39 (78.0)
12 (28.6)
36 (72.0)
37.3 ± 23.5
4.3 ± 2.1

24 (27.0)
28.8 ± 6.7
21.7 ± 4.5
24.5 ± 5.7
7.1 ± 5.7
2.85 ± 3.82
42 (75.0)
23 (32.9)
22 (24.7)
24.7 ± 16.4
3.9 ± 1.6

0.233
0.128
< 0.001
< 0.001
< 0.001
< 0.001
0.716
0.636
< 0.001
0.002
0.163

JoAS: juvenile-onset ankylosing spondylitis
AoAS: adult-onset ankylosing spondylitis
BASDAI: Bath Ankylosing Apondylitis Disease Activity Index
BASFI: Bath Ankylosing Apondylitis Functional Index
SD: Standard deviation
HLA: human leukocyte antigen

were detected in BASDAI between JoAS and AoAS (4.25
± 2.08 vs. 3.96 ± 1.95; P = 0.163) in the present study
either. Radiographic sacroiliitis is a mandatory item in
the modified New York criteria of AS, which has long
been regarded as one of the most common reasons for
the diagnosis delay of AS (21). With respect to patients
with JoAS, this indispensable item might act as more of
an obstruction to early diagnosis of AS (5,7). It has been
consistently reported that JoAS patients experience a more
frequent onset of peripheral joint involvement (6) and a
significantly late onset, and less severe, axial involvement
(19). Patients with JoAS in our cohort also showed a
more frequent onset of peripheral joint involvement than
patients with AoAS (P < 0.001). Although patients with

JoAS in this study were often correctly diagnosed with AS
at a significantly younger age compared with patients with
AoAS (18.5 ± 5.2 vs. 24.5 ± 5.7; P < 0.001), they were still
more likely to suffer from longer diagnosis delays than
patients with AoAS (5.32 ± 5.26 vs. 2.85 ± 3.82; P < 0.001).
Functional status in JoAS was significantly worse than
that in AoAS (BASFI: 37.33 ± 23.45 vs. 24.71 ± 16.39; P =
0.002). As mentioned above, this result is consistent with
most of the previous studies (7,10) while inconsistent with
some other studies that showed either no differences at
all (6) or contrary results (4). Differing study designs may
have contributed to these discrepancies.
So far, most of the studies focused solely on the
differences in clinical characteristics between JoAS and
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AoAS while the potential differences in the disease’s impact
on life received relatively little attention (6). Educational
level has been reported as an important factor that affects
the comprehensive quality of life in AS patients (22). A high
level of education also helps opens up more opportunities
for employment (23). However, this may actually be a
vicious cycle. Different educational levels can affect AS
patients’ quality of life in different areas. Different types of
AS, namely JoAS and AoAS, may also affect patients’ access
to education to a certain extent. With an early onset of AS
symptom, patients with JoAS may be more likely to drop
out of school before university or college. In this study,
patients with JoAS showed a significantly lower rate of
receiving higher education (P = 0.037). This result implies
that certain supporting measures will benefit patients with
JoAS, significantly helping them to continue with school
until they enter university or college. Employment status
can affect not only patients’ economic burdens but also
their psychosocial status, which are all essential parts of
a comprehensive quality of life (24–26). In our cohort,
the rate of employment in the JoAS group was lower than
that in the AoAS group (47.6% vs. 59.8%). Although the
difference did not reach a significant level, the JoAS group
included more patients who had not been employed since
they reached the age of adulthood (P = 0.015). It indicates
that certain interventions of occupational guidance as
well as occupational training may benefit AS patients
substantially, especially patients with JoAS. Marriage is no
doubt an important part of life. Nevertheless, it is reported
that AS patients may have low marriage rates and high rates
of divorce (27). Patients with JoAS, however, may be facing
an even worse marital situation. In the present study,

patients with JoAS showed significantly lower rates of
getting married (P = 0.013) compared with patients
with AoAS. The good news may be that only 1 patient
in all of the 139 participants experienced divorce, which
is inconsistent with a previous report (27). This might
be partly related to the traditional Chinese approach
towards marriage and family. It should be noted that
simple marriage guidance may not help AS patients
fully enough. Psychological interventions may be also
necessary. Moreover, the improvement of educational
level and employment status may also play a role in
marital status. Further study of this aspect is warranted.
There are certain limitations in this study. First,
participants were representative of patients living in
urban centers with more access to a higher quality
of AS treatment, more opportunities to get a college
education, and more job opportunities. AS patients in
rural and remote areas might be facing an even more
severe reality and that warrants further investigation.
Second, since this is a retrospective study, there might
be a recall bias in questioning patients about the date
of symptom onset and date of diagnosis. However, this
bias may exist in most of the patients and thus dilute the
deviation effect.
In conclusion, early diagnosis of JoAS is an even
more severe challenge compared with AoAS and specific
diagnosing criteria for JoAS are warranted. Patients with
JoAS showed worse functional status than patients with
AoAS and more aggressive treatment may be needed for
JoAS. Certain interventions to counteract the disease’s
impact on the quality of life of AS patients are required,
especially for patients with JoAS.
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